3 investment funds that could turbocharge a Stocks and Shares ISA

Edward Sheldon highlights three niche investment funds producing market-beating returns for investors, thanks to powerful, long-term trends.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young Asian man drinking coffee at home and looking at his phone

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investing in ‘thematic’ investment funds can be a good way to boost an ISA’s performance. By directing capital towards high-growth markets, this can potentially generate higher-than-average returns.

Here, I’m going to highlight three such funds that I believe are worth a closer look today. I think these products have the potential to turbocharge an ISA in the years ahead.

Schroder Global Healthcare

First up is the Schroder Global Healthcare fund. As its name suggests, this is focused on healthcare companies.

The reason I’m bullish here is that the healthcare industry looks set for strong growth in the decade ahead, thanks to the world’s ageing population. By 2030, around 1.4bn people globally will be aged 60 or over – 40% higher than in 2020. This should increase demand for healthcare services significantly.

Poor health associated with ageing is the next epidemic

Aetna International

This fund provides diversified exposure to the industry. Currently, it’s invested in nearly 70 different companies. Top holdings include the likes of medical instrument maker Thermo Fisher Scientific, diabetes specialist Eli Lilly, and UK-listed pharma giant AstraZeneca – all great businesses.

Long-term performance here has been very strong. Over the last five years, the fund has returned about 84% (versus 21% for the FTSE 100). Of course, past performance is not an indicator of future returns. However, all things considered, I think this fund has a lot of potential going forward.

  • 1-year return: 9%
  • 5-year return: 84%

Fidelity Global Technology

Next up, we have Fidelity Global Technology. This is focused specifically on tech companies.

Technology plays a major role in our lives these days. And looking ahead, it’s likely to play an even larger role as the world becomes more digital.

I see this fund is a good way to capitalise. It’s invested in around 100 different tech companies ranging from big players such as Apple and Alphabet to smaller players such as Salesforce and Qualcomm. So it provides diversified exposure to the industry.

Long-term performance here has been excellent. Over the last five years, the fund has returned about 133%. That said, it has experienced weakness at times due to the fact that tech shares are volatile.

I expect the fund to do well over the long run however, given the impact technology is having on the world today.

  • 1-year return: 10%
  • 5-year return: 133%

Sanlam Global Artificial Intelligence

Finally, we have the Sanlam Global Artificial Intelligence fund. This product – which is higher risk – is focused on companies that are active in the artificial intelligence (AI) space.

AI looks set to disrupt nearly every industry over the next decade. And it should create some lucrative investment opportunities in the process.

I think this fund is a great way to get exposure to the theme as it invests in companies using AI to their benefit. Top holdings include Alphabet, Microsoft, and Nvidia, which I see as three of the best AI stocks at present.

AI will permeate almost all areas of the global economy

Chris Ford, Sanlam Global Artificial Intelligence Fund Manager

Because of its niche focus, this fund can be volatile. Last year, for example, the fund produced double-digit losses.

Since its inception in 2017 however, it has done very well, returning about 17.5% per year (to the end of March).

I believe that in the long run, it will continue to outperform.

  • 1-year return: 9%
  • 5-year return: 91%

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has positions in Alphabet, Apple, Microsoft, and Nvidia, Schroder Global Healthcare, and the Sanlam Global Artificial Intelligence fund. The Motley Fool UK has recommended Alphabet, Apple, Microsoft, Nvidia, Qualcomm, and Salesforce. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Buffett at the BRK AGM
Investing Articles

I’ve just met Warren Buffett’s first rule of investing. Here are 3 ways I did it

Harvey Jones has surprised himself by living up to Warren Buffett's most important investment rule. But is his success down…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Down 51% in 2024, is this UK growth stock a buy for my Stocks and Shares ISA?

Ben McPoland considers Oxford Nanopore Technologies (LSE:ONT), a UK growth stock that has plunged over 80% since going public in…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

These 3 growth stocks still look dirt cheap despite the FTSE hitting all-time highs

Harvey Jones is hunting for growth stocks that have missed out on the recent FTSE 100 rally and still look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Here’s how much I’d need to invest in UK income stocks to retire on £25k a year

Harvey Jones is building his retirement plans on a portfolio of top UK dividend income stocks. There are some great…

Read more »

Investing Articles

If I’d invested £5,000 in BT shares three months ago here’s what I’d have today

Harvey Jones keeps returning to BT shares, wondering whether he finally has the pluck to buy them. The cheaper they…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’d aim for a million, by investing £150 a week

Our writer outlines how he’d aim for a million in the stock market through regular saving, disciplined investing, and careful…

Read more »

Investing Articles

Here’s how the NatWest dividend could earn me a £1,000 annual passive income!

The NatWest dividend yield is over 5%. So if our writer wanted to earn £1,000 in passive income each year,…

Read more »

Young female hand showing five fingers.
Investing Articles

I’d start buying shares with these 5 questions

Christopher Ruane shares a handful of selection criteria he would use to start buying shares -- or invest for the…

Read more »